B. OPV-2
| . | . | All Positive Samples by Time from OPV . | All Positive Samples Collected in 42 days from OPV . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | . | ≤3 Days from Vaccination . | 4–21 Days from Vaccination . | 22–42 Days from Vaccination . | All Records . | One Record per Infant . | ||||||
| . | . | N (%)a . | % Revertant . | N (%)a . | % Revertant . | N (%)a . | % Revertant . | N . | % Revertant . | N^ . | % Revertant . | P Value . |
| OPV-naive (1 dose) | HIV– | 8 (15) | 100 | 6 (11) | 83 | 40 (74) | 100 | 54 | 98 | 54 | 98 | .001 |
| HIV+ | 0 (0) | ... | 3 (33) | 33 | 6 (67) | 67 | 9 | 56 | 9 | 56 | ||
| OPV exposed (≥2 doses) | HIV– | 46 (42) | 91 | 41 (38) | 86 | 22 (20) | 83 | 109 | 87 | 95 | 87 | .01 |
| HIV+ | 4 (18) | 75 | 8 (36) | 63 | 10 (45) | 70 | 22 | 68 | 18 | 61 | ||
| Alla | HIV– | 54 (33) | 93 | 47 (29) | 83 | 62 (38) | 95 | 163 | 91 | 142 | 92 | <.0001 |
| HIV+ | 4 (13) | 75 | 11 (35) | 55 | 16 (52) | 68 | 31 | 65 | 25 | 56 | ||
| . | . | All Positive Samples by Time from OPV . | All Positive Samples Collected in 42 days from OPV . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | . | ≤3 Days from Vaccination . | 4–21 Days from Vaccination . | 22–42 Days from Vaccination . | All Records . | One Record per Infant . | ||||||
| . | . | N (%)a . | % Revertant . | N (%)a . | % Revertant . | N (%)a . | % Revertant . | N . | % Revertant . | N^ . | % Revertant . | P Value . |
| OPV-naive (1 dose) | HIV– | 8 (15) | 100 | 6 (11) | 83 | 40 (74) | 100 | 54 | 98 | 54 | 98 | .001 |
| HIV+ | 0 (0) | ... | 3 (33) | 33 | 6 (67) | 67 | 9 | 56 | 9 | 56 | ||
| OPV exposed (≥2 doses) | HIV– | 46 (42) | 91 | 41 (38) | 86 | 22 (20) | 83 | 109 | 87 | 95 | 87 | .01 |
| HIV+ | 4 (18) | 75 | 8 (36) | 63 | 10 (45) | 70 | 22 | 68 | 18 | 61 | ||
| Alla | HIV– | 54 (33) | 93 | 47 (29) | 83 | 62 (38) | 95 | 163 | 91 | 142 | 92 | <.0001 |
| HIV+ | 4 (13) | 75 | 11 (35) | 55 | 16 (52) | 68 | 31 | 65 | 25 | 56 | ||
^Multiple samples from the same infant: HIV–: 14 with 2 samples, 2 with 3 samples, 1 with 4 samples; HIV+: 4 with 2 samples, 1 with 3 samples.
a Percent of all samples collected in 42 days from vaccination.
B. OPV-2
| . | . | All Positive Samples by Time from OPV . | All Positive Samples Collected in 42 days from OPV . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | . | ≤3 Days from Vaccination . | 4–21 Days from Vaccination . | 22–42 Days from Vaccination . | All Records . | One Record per Infant . | ||||||
| . | . | N (%)a . | % Revertant . | N (%)a . | % Revertant . | N (%)a . | % Revertant . | N . | % Revertant . | N^ . | % Revertant . | P Value . |
| OPV-naive (1 dose) | HIV– | 8 (15) | 100 | 6 (11) | 83 | 40 (74) | 100 | 54 | 98 | 54 | 98 | .001 |
| HIV+ | 0 (0) | ... | 3 (33) | 33 | 6 (67) | 67 | 9 | 56 | 9 | 56 | ||
| OPV exposed (≥2 doses) | HIV– | 46 (42) | 91 | 41 (38) | 86 | 22 (20) | 83 | 109 | 87 | 95 | 87 | .01 |
| HIV+ | 4 (18) | 75 | 8 (36) | 63 | 10 (45) | 70 | 22 | 68 | 18 | 61 | ||
| Alla | HIV– | 54 (33) | 93 | 47 (29) | 83 | 62 (38) | 95 | 163 | 91 | 142 | 92 | <.0001 |
| HIV+ | 4 (13) | 75 | 11 (35) | 55 | 16 (52) | 68 | 31 | 65 | 25 | 56 | ||
| . | . | All Positive Samples by Time from OPV . | All Positive Samples Collected in 42 days from OPV . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| . | . | ≤3 Days from Vaccination . | 4–21 Days from Vaccination . | 22–42 Days from Vaccination . | All Records . | One Record per Infant . | ||||||
| . | . | N (%)a . | % Revertant . | N (%)a . | % Revertant . | N (%)a . | % Revertant . | N . | % Revertant . | N^ . | % Revertant . | P Value . |
| OPV-naive (1 dose) | HIV– | 8 (15) | 100 | 6 (11) | 83 | 40 (74) | 100 | 54 | 98 | 54 | 98 | .001 |
| HIV+ | 0 (0) | ... | 3 (33) | 33 | 6 (67) | 67 | 9 | 56 | 9 | 56 | ||
| OPV exposed (≥2 doses) | HIV– | 46 (42) | 91 | 41 (38) | 86 | 22 (20) | 83 | 109 | 87 | 95 | 87 | .01 |
| HIV+ | 4 (18) | 75 | 8 (36) | 63 | 10 (45) | 70 | 22 | 68 | 18 | 61 | ||
| Alla | HIV– | 54 (33) | 93 | 47 (29) | 83 | 62 (38) | 95 | 163 | 91 | 142 | 92 | <.0001 |
| HIV+ | 4 (13) | 75 | 11 (35) | 55 | 16 (52) | 68 | 31 | 65 | 25 | 56 | ||
^Multiple samples from the same infant: HIV–: 14 with 2 samples, 2 with 3 samples, 1 with 4 samples; HIV+: 4 with 2 samples, 1 with 3 samples.
a Percent of all samples collected in 42 days from vaccination.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
